Growing insights into the potential benefits and risks of activated protein C administration in sepsis: a review of preclinical and clinical studies

Laith Altaweel, Daniel Sweeney, Xizhong Cui, Amisha Barochia, Charles Natanson, Peter Q EichackerCritical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USAAbstract: Recombinant human activated protein C (rhAPC) was developed to reduce excessive coagulant and...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Laith Altaweel, Daniel Sweeney, Xizhong Cui, et al
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2009
Materias:
Acceso en línea:https://doaj.org/article/25811bbb6b944277b5ba7fd51db1aa93
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares